CPHI$0.6093+0.49%
China Pharma Holdings, Inc.
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: NYSE
Mkt Cap:$26.21M
Float & O/S:42.7M / 43.02M
Inst Own:0.5%
DilutionScan read 7 of CHINA PHARMA HOLDINGS, INC.'s SEC filings and found 3 warrant series, 1 ATM program, 1 equity line, 2 shelf registrations and 2 completed offerings on file for CPHI. The latest dilution event on file is an offering on Jul 23, 2026. Analysis updated Aug 27, 2026.
Signal8 Summary
CPHI
Cash-strapped micro-cap diluting shareholders
Snapshot
China Pharma is a tiny Chinese generic-drug maker with $4.1M in FY 2025 revenue, down 8.5% YoY, and a negative gross margin, meaning it's losing money just making its products before other costs.
What's Happening Right Now
- : The $2.00 offering price was priced at a steep 75% discount to the prior closing price of $8.10, a sign of a distressed, highly dilutive capital raise.
- : On Jul 23, 2026, China Pharma closed a $5 million registered direct offering, selling 2.5 million new shares at $2.00 each.
- : Raised $5.00M in gross proceeds through a registered direct offering.
- : Following unusual trading activity in mid-July 2026, NYSE American contacted the company, which stated it knew of no undisclosed developments explaining the volatility.
- : Registered $50.00M of securities for sale on Form S-3.
